Omodenbamab immunoglobulin, designated identified as 2241724-48-9, represents: is a novel monoclonal read more protein currently subject to investigation for: concerning its anticipated therapeutic applications: uses, specifically targeting adenylyl cyclase type 2. Investigators continue to explorin